Research Article
SIAE Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies
Table 1
Clinical and demographic characteristics of the patients and controls of the study.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AHA: autoimmune hemolytic anemia; aJIA: autoimmune juvenile idiopathic arthritis; CVID: common variable immunodeficiency; JIA: juvenile idiopathic arthritis; IgAD: IgA deficiency; ITP, idiopathic thrombocytopenic purpura; PADs, primary antibody deficiencies; sJIA, systemic juvenile idiopathic arthritis. aArthritis is reported in each group regardless of the autoimmune background, bincluding patients with lupus, catastrophic antiphospholipid syndrome, Raynaud’s syndrome, and autoimmune neutropenia. |